Use of an Inhibition Enzyme-Linked Immunosorbent Assay for Quantification of Capsular Polysaccharide or Proteins in Vaccines

Altman, E., J.-R. Brisson, and M. B. Perry. 1988. Structural studies of the capsular polysaccharide from Actinobacillus (Haemophilus) pleuropneumoniae serotype 4. Biochem. Cell Biol.66:998-1004.

Anderson, P. 1978. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J. Immunol.120:866-870.

Blackall, P. J., H. L. Klaasen, H. van den Bosch, P. Kuhnert, and J. Frey. 2002. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet. Microbiol.84:47-52.

10.1128/iai.58.12.3829-3832.1990

Frey, J. 1994. RTX-toxins in Actinobacillus pleuropneumoniae and their potential role in virulence, p. 325-340. In C. I. Kado and J. H. Crosa (ed.), Molecular mechanisms of bacterial virulence. Kluwer Academic Publishers, Amsterdam, The Netherlands.

Frey, J. 1995. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol.3:257-261.

Harlow, E., and D. Lane. 1988. Antibodies: a Laboratory manual, p. 553-612. Cold Spring Harbor, New York, NY.

10.1128/iai.55.7.1573-1579.1987

10.1128/jcm.33.9.2297-2303.1995

Inzana, T. J. 1991. Virulence properties of Actinobacillus pleuropneumoniae. Microb. Pathog.11:305-316.

10.1128/jcm.28.2.312-318.1990

10.1128/JCM.39.4.1279-1282.2001

10.1128/iai.56.11.2830-2837.1988

10.1128/iai.55.7.1580-1587.1987

Inzana, T. J., J. Todd, J. N. Ma, and H. Veit. 1991. Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5: role of the 110 kilodalton hemolysin in virulence and immunoprotection. Microb. Pathog.10:281-296.

10.1128/iai.61.5.1682-1686.1993

10.1128/iai.59.9.3079-3085.1991

10.1128/jcm.27.6.1187-1191.1989

10.1128/jcm.28.6.1356-1361.1990

Ma, J., and T. J. Inzana. 1992. Rapid purification of a 110-kilodalton hemolysin of Actinobacillus pleuropneumoniae by monoclonal antibody-affinity chromatography. Am. J. Vet. Res.53:59-62.

Martin, P. G., P. Lachance, and D. F. Niven. 1985. Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae. Can. J. Microbiol.31:456-462.

Nielsen, R. 1979. Haemophilus parahaemolyticus serotypes—pathogenicity and cross immunity. Nord. Vet. Med.31:407-413.

Nielsen, R. 1984. Haemophilus pleuropneumoniae serotypes—cross protection experiments. Nord. Vet. Med.36:221-234.

Odeyale, C. O., and Y. H. Kang. 1988. Biotinylation of bacterial lipopolysaccharide and its applications to electron microscopy. J. Histochem. Cytochem.36:1131-1137.

Perry, M. B., E. Altman, J.-R. Brisson, L. M. Beynon, and J. C. Richards. 1990. Structural characteristics of the antigenic capsular polysaccharides and lipopolysaccharides involved in the serological classification of Actinobacillus (Haemophilus) pleuropneumoniae strains. Serodiagn. Immunother.4:299-308.

Reimer, D., J. Frey, R. Jansen, H. P. Veit, and T. J. Inzana. 1995. Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb. Pathog.18:197-209.

Rosendal, S., J. Devenish, J. I. MacInnes, J. H. Lumsden, S. Watson, and H. Xun. 1988. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae. Am. J. Vet. Res.49:1053-1058.

Schaller, A., R. Kuhn, P. Kuhnert, J. Nicolet, T. J. Anderson, J. I. MacInnes, R. P. Segers, and J. Frey. 1999. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology (Reading, England)145:2105-2116.

Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis.126:514-521.